Navigation Links
Boehringer Ingelheim Initiates NEwArT Study Comparing Viramune(R) (nevirapine) to a Ritonavir-Boosted Atazanavir-based Regimen in Treatment-Naive HIV Patients
Date:11/28/2007

RIDGEFIELD, Conn., Nov. 28 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc., makers of Viramune(R) (nevirapine) tablets, announced today that it has begun to enroll patients in the NEwArT study to include 18 planned sites across the United States. The goal of the NEwArT study is to compare the efficacy and safety of VIRAMUNE, a non-nucleoside reverse transcriptase inhibitor (NNRTI) versus atazanavir, a protease inhibitor (PI) boosted with ritonavir. Both agents will be combined with the fixed dose combination of tenofovir and emtricitabine (Truvada(R)). The NEwArT trial will enroll 150 HIV-positive patients who have not previously been treated with antiretroviral drugs.

"The NEwArT trial may help patients and physicians better understand the role of nevirapine within today's evolving treatment strategies and provide more information on selecting treatment options for first-line therapy in HIV-positive patients," explained lead study investigator Edwin DeJesus, M.D., medical director of the Orlando Immunology Center.

The NEwArT (efficacy and safety of NEvirapine compared With Atazanavir boosted with Ritonavir and a background of Truvada in HIV-1 infected patients who have received no previous antiretroviral treatment) study is a Phase IV, open-label, randomized, multicenter trial with a primary endpoint of virologic response at 48 weeks, defined as a viral load <50 copies/mL at two consecutive visits prior to Week 48 and without subsequent rebound or change of antiretroviral therapy by Week 48. Secondary endpoints will include an evaluation of change in fasting lipids.

Patients will be randomized to receive either 200 mg of VIRAMUNE twice daily or 300 mg of atazanavir boosted with 100 mg of ritonavir once daily. Patients in the VIRAMUNE arm will begin their treatment with 200 mg once daily increased to 200 mg twice daily after two weeks. The current VIRAMUNE CD4+ cell criteria are being applied to both arms of the study. All pati
'/>"/>

SOURCE Boehringer Ingelheim Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Carrington Subsidiary DelSite Initiates Critical Toxicology Studies of Its Nasal Powder Bird Flu Vaccine
2. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
3. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
4. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
5. MedImmune Initiates Phase 2a Multi-Dose Study in Patients with Asthma
6. Genta Initiates Phase 3 AGENDA Trial of Genasense(R) for Patients with Advanced Melanoma
7. Nuvelo Re-Initiates SONOMA-3 Trial of Alfimeprase in Patients With Catheter Occlusion
8. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
9. Prolexys Pharmaceuticals Initiates Phase 1 Study
10. Isis Initiates Phase 1 Study of ISIS 325568 Targeting Glucagon Receptor to Treat Type 2 Diabetes
11. Lpath Demonstrates Preclinical Efficacy of Lpathomab(TM) and Initiates Humanization Process
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... Jan. 15, 2014 Most osteoporosis patients want a ... recent online survey* sponsored by Mission Pharmacal Company. The ... Osteoporosis Foundation online support community, revealed that 74 percent ... comes in a form other than a pill or ...
(Date:1/15/2014)... 2014  Celsion Corporation (the "Company") (NASDAQ: CLSN ... institutional investors to purchase an aggregate of approximately $15 ... registered direct offering, led by a dedicated health care ... agreements with these investors pursuant to which the Company ...
(Date:1/15/2014)... LOUISVILLE, Ky. , Jan. 15, 2014  Manufacturers, ... technologies must be able to protect their most ... (Logo: http://photos.prnewswire.com/prnh/20130716/CL46586LOGO ) Because ... Industry, it steadfastly remains one of the most ...
Breaking Medicine Technology:Mission Pharmacal Conducts Online Survey of Osteoporosis Patients 2Mission Pharmacal Conducts Online Survey of Osteoporosis Patients 3Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 2Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 3Intellectual Property Insurance for Medical-related Products and Services 2
... WORTH, Texas, March 22, 2012  The Board of Directors of ... innovator in advanced wound care solutions, announced today that Robert ... of the Company.  In addition, Scott A. Haire has resigned ... Executive Officer of the Company, and Deborah Jenkins Hutchinson has ...
... 22, 2012  Argon Medical Devices, Inc. announced today ... catheter, licensed from Rex Medical, LP, designed to ... treatments. "UltraStream provides clinicians with an ... life for their patients," commented George Leondis, President ...
Cached Medicine Technology:Wound Management Technologies Names Robert Lutz, Jr. as New CEO; Buys Back North American Distribution Rights for CellerateRX® Powder 2Wound Management Technologies Names Robert Lutz, Jr. as New CEO; Buys Back North American Distribution Rights for CellerateRX® Powder 3Argon Medical Devices Announces The Launch of a Unique New Chronic Hemodialysis Catheter 2
(Date:7/11/2014)... Seattle, WA (PRWEB) July 11, 2014 ... but the rate of return to play has not ... at the American Orthopaedic Society for Sports Medicine’s ( ... for NFL players is approximately 90 percent no matter ... study highlighted the success rate of return to play ...
(Date:7/11/2014)... SEATTLE, WA Anterior Cruciate Ligament (ACL) reconstructions occur ... of material used to create a new ligament may ... researchers presenting their work today at the Annual Meeting ... , "Our study results highlight that in ... donor) fail more frequently than using autografts (tissue harvested ...
(Date:7/11/2014)... Woodland Hills permanent teeth in one day ... Art Institute in Woodland Hills and Oxnard, Calif., will speak ... Del Rey, Calif. , The award-winning prosthodontist, international speaker ... teeth in one day dental procedure at 1:30 p.m. Friday, ... developed 15 years ago, Dr. Jivraj said. Getting new teeth ...
(Date:7/11/2014)... (PRWEB) July 11, 2014 The World Cup ... according to recent reports , many star soccer players left ... in the media to American football when it comes to ... risk is always there. While none of the soccer superstars ... possibility remains. Beverly Hills spine surgeon Dr. Gravori reveals some ...
(Date:7/11/2014)... On Tuesday, July 9, Eric D. ... office joined CBS affiliate WUSA’s Andrea Roane on ... audience about the number of ways Shady Grove Fertility ... possible for women after they undergo cancer treatment. ... in the developing field known as oncofertility which Dr. ...
Breaking Medicine News(10 mins):Health News:Stabilizing Shoulder Surgery Helps NFL Players Return to the Game 2Health News:ACL reconstructions may last longer with autografts 2Health News:Woodland Hills Dental Expert Speaking at Nobel Biocare World Symposium in One Week 2Health News:Woodland Hills Dental Expert Speaking at Nobel Biocare World Symposium in One Week 3Health News:Woodland Hills Dental Expert Speaking at Nobel Biocare World Symposium in One Week 4Health News:Woodland Hills Dental Expert Speaking at Nobel Biocare World Symposium in One Week 5Health News:As World Cup Comes to an End, Injuries are Star of the Show 2Health News:As World Cup Comes to an End, Injuries are Star of the Show 3Health News:Baby After Cancer Is a Reality as Shady Grove Fertility Provides Successful Treatment for Cancer Survivors 2Health News:Baby After Cancer Is a Reality as Shady Grove Fertility Provides Successful Treatment for Cancer Survivors 3Health News:Baby After Cancer Is a Reality as Shady Grove Fertility Provides Successful Treatment for Cancer Survivors 4
... choose to admit it or not, we all experience memory ... memory may be a result of having too many other ... passed. However, previous studies have indicated that a specific type ... reasons. Boundary extension is a mistake that we often make ...
... get into fights , , WEDNESDAY, Oct. 29 (HealthDay News) -- ... entertainment in the media are far less likely to engage ... at a slice in time, so I can,t tell you ... the reverse that violent kids are looking for violent media," ...
... study raises the question, do barriers to health ... risk of tuberculosis? The study, published in the ... Diseases and now available online, suggests that ... seeking care than documented immigrants or U.S.-born patients, ...
... Caregivers strike at 10 hospitals owned by Sutter Health ... Members of SEIU,United Healthcare Workers-West (UHW) are on strike ... hospitals owned by Daughters of Charity,Health System (DOCHS), and ... and bad-faith negotiation by hospital management., At three ...
... and Online Content to Fight,Mental Health Stigma and ... YORK, Oct. 29 mtvU, MTV,s 24-hour college ... to reduce emotional,distress and prevent suicide among college ... campaign with new content launching,today that encourages students ...
... and climate change as culprits , , WEDNESDAY, Oct. 29 ... year from infectious diseases, and that number could increase ... news was delivered in a report, Germs Go ... America , released Wednesday by the Trust for America,s ...
Cached Medicine News:Health News:Our cheatin' brain: The brain's clever way of showing us the world as a whole 2Health News:Less Exposure to Violent Media Makes Youths Less Aggressive 2Health News:Less Exposure to Violent Media Makes Youths Less Aggressive 3Health News:Health-care barriers for undocumented immigrants: Raising tuberculosis risk? 2Health News:United Healthcare Workers Stand Up For Patients in Statewide Hospital Strike 2Health News:mtvU and The Jed Foundation Ask Students 'How Are You A Friend?' 2Health News:mtvU and The Jed Foundation Ask Students 'How Are You A Friend?' 3Health News:mtvU and The Jed Foundation Ask Students 'How Are You A Friend?' 4Health News:mtvU and The Jed Foundation Ask Students 'How Are You A Friend?' 5Health News:mtvU and The Jed Foundation Ask Students 'How Are You A Friend?' 6Health News:Threat From Infectious Diseases Growing 2Health News:Threat From Infectious Diseases Growing 3
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: